Pharma Industry News
A collection of Pharma latest news, analysis and best practices from top business influencers and the world's most trustworthy sources.
Vistin Pharma ASA (OB: VISTN) Stock Ex-Dividend Deadline Approaches as Income Investors Weigh Payout Sustainability
Income-focused investors in Vistin Pharma ASA (OB: VISTN) have a narrow window remaining to qualify for the Norwegian pharmaceutical company's next dividend payment. The ex-dividend date falls on May 22, meaning any investor who has not settled a…
Commerzbank Aktiengesellschaft FI Invests $982,000 in Royalty Pharma PLC $RPRX
Commerzbank Aktiengesellschaft FI purchased a new position in Royalty Pharma PLC (NASDAQ:RPRX - Free Report) during the 4th quarter, according to its most recent 13F filing with the SEC. The firm purchased 25,417 shares of the biopharmaceutical…
Qsemble Capital Management LP Invests $2.88 Million in Royalty Pharma PLC $RPRX
Qsemble Capital Management LP acquired a new position in Royalty Pharma PLC (NASDAQ:RPRX - Free Report) in the fourth quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The fund acquired 74,416…
HRF alleges unchecked industrial effluent discharge in Anakapalli district
The Human Rights Forum (HRF) has alleged large-scale discharge of untreated and inadequately treated industrial effluents into water bodies in the Atchutapuram-Rambilli industrial corridor of Anakapalli district, and demanded immediate intervention…
Buying What Markets Ignore
Motilal Oswal Mutual Fund has entered the contra fund category with an NFO in May, adding to a relatively under-populated segment that currently houses only three schemes: SBI Contra, Invesco India Contra and Kotak India EQ Contra Fund. The launch…
KIA crosses 400 million passenger milestone in April
Kempegowda International Airport (KIA), Bengaluru, crosses the 400 million passenger milestone since its Airport Opening Day (AOD), in April, 2026. The airport also registered a strong growth in the financial year 2025-26, driven by international…
SRF: On The Road to Recovery
SRF reported its Q4FY26 results in early May and provided a strong outlook. We had earlier recommended a hold on the stock in August 2025 because valuations were elevated at 44 times one-year forward earnings even when factoring for expectations of…
Opinion | How Low Can America Go?
For many doctors like me, Donald G. McNeil Jr.'s byline will always inspire respect. A New York Times (NYT) reporter since the 1970s, he first earned his medical stripes in the 1990s as a foreign correspondent covering HIV/AIDS in South Africa.
Millennium Capital Advisors LLC Purchases New Shares in AbbVie Inc. $ABBV
Millennium Capital Advisors LLC purchased a new stake in AbbVie Inc. (NYSE:ABBV - Free Report) in the fourth quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The firm purchased 11,875 shares…
AbbVie Inc. $ABBV Shares Sold by WealthPlan Investment Management LLC
WealthPlan Investment Management LLC trimmed its stake in shares of AbbVie Inc. (NYSE:ABBV - Free Report) by 21.7% in the 4th quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional…
AbbVie (NYSE:ABBV) Rating Lowered to Buy at Wall Street Zen
AbbVie (NYSE:ABBV - Get Free Report) was downgraded by research analysts at Wall Street Zen from a 'strong-buy' rating to a 'buy' rating in a report released on Sunday. The Most Important Part of These 3 Big Pharma Earnings Reports Wasn't the Beat…
Soltis Investment Advisors LLC Acquires 12,096 Shares of AbbVie Inc. $ABBV
Soltis Investment Advisors LLC lifted its holdings in shares of AbbVie Inc. (NYSE:ABBV - Free Report) by 55.0% in the 4th quarter, according to its most recent filing with the Securities and Exchange Commission. The firm owned 34,077 shares of the…
The Goldman Sachs Group, Inc. $GS Position Increased by May Hill Capital LLC
May Hill Capital LLC raised its holdings in shares of The Goldman Sachs Group, Inc. (NYSE:GS - Free Report) by 101.3% in the fourth quarter, according to its most recent Form 13F filing with the SEC. The institutional investor owned 2,402 shares of…
L & S Advisors Inc Has $8.01 Million Stake in AbbVie Inc. $ABBV
L & S Advisors Inc lowered its stake in shares of AbbVie Inc. (NYSE:ABBV - Free Report) by 18.2% in the fourth quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The firm owned 35,064 shares of the company's…
Barr E S & Co. Sells 2,597 Shares of The Goldman Sachs Group, Inc. $GS
Barr E S & Co. lowered its holdings in The Goldman Sachs Group, Inc. (NYSE:GS - Free Report) by 1.7% during the fourth quarter, according to the company in its most recent Form 13F filing with the SEC. The institutional investor owned 146,426…
Receive a Daily briefing on Pharma Industry News
Get Started